In This Article:
We recently published a list of Top 10 Must-See AI News And Ratings For Investors. In this article, we are going to take a look at where Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) stands against other top must-see AI news and ratings for investors.
A high US inflation print has diminished hopes of interest rate cuts by the Federal Reserve, which triggered a downdraft in the US stock markets as the S&P 500 index fell 0.27% to 6051.97 on February 12th, led by share price declines witnessed by several of the magnificent seven companies.
Meanwhile, industry experts are forecasting that DeepSeek’s open-source nature and low fees could drive AI adoption and the development of real-life applications for the technology, which could enable Chinese firms to overcome US export limitations on their powerful chips. Furthermore, dozens of Chinese firms across industries are mulling the integration of DeepSeek’s AI model into their products and business operations.
“This development is very much aligned with the capability of Chinese AI chipset vendors,” said Lian Jye Su, a chief analyst at Omdia. “Chinese AI chipsets struggle to compete with Nvidia’s GPU (graphics processing unit) in AI training, but AI inference workloads are much more forgiving and require a lot more local and industry-specific understanding.”
We selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey’s database of 900 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
A biotechnology worker carefully inspecting a vial of cell samples through a microscope.
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP)
Number of Hedge Fund Holders: 4
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) is a biopharma company that uses AI to design and innovate targeted cell therapies for various diseases, such as cancer, autoimmune, and infectious diseases to improve patient outcomes.
On February 13th, Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) announced the launch of its new investment arm, COEP Venture Group, to accelerate tech startups focusing on AI-driven enterprise solutions, Robotic Process Automation, and AI agents by offering capital, strategic mentorships, and access to industry networks.